Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00746668 · ClinicalTrials.gov registry record · NA
A Multi-Center Study of Reading Rehabilitation in Macular Disease
A NA study of Retinal Degeneration and Age-related Maculopathy, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00746668: Completed NA study of Retinal Degeneration and Age-related Maculopathy, sponsored by US Department of Veterans Affairs.
NCT00746668 is a NA study of Retinal Degeneration and Age-related Maculopathy that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 36 participants, below the 339-participant average among 17 other Retinal Degeneration trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00746668, a NA study of Retinal Degeneration and Age-related Maculopathy, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with macular disease, including age-related macular degeneration.
Primary Outcome
To assess reading performance, after each training module (1-3), two lines of text were presented at the center of the monitor. Each subject was seated with his or her forehead on a head rest at a viewing distance of 40cm. The subject read each sentence aloud and indicated whether it made sense by responding true or false. Reading speed was calculated using an algorithm similar to that used for the MNRead test. The number of words read correctly was divided by the time required to read the sente
Conditions Studied
Interventions
- BEHAVIORAL Module 1: Visual Awareness and Eccentric Viewing
- BEHAVIORAL Module 2: Control of Reading Eye Movements
- BEHAVIORAL Module 3: Reading Practice with RSVP
Study Locations (1)
Illinois
- Jesse Brown VAMC (WestSide Division) - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT00746668 record still lists
NCT00746668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 339-participant average among 17 other Retinal Degeneration trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Retinal Degeneration appearing as the primary indexed condition, and to 3 interventions - of which Module 1: Visual Awareness and Eccentric Viewing is the first listed.
NCT00746668 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00746668 about?
NCT00746668 is a clinical study titled "A Multi-Center Study of Reading Rehabilitation in Macular Disease". The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with macular disease, including age-related macular degeneration.
What is the current status of trial NCT00746668?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2008-08. Estimated completion is 2012-09.
What conditions does trial NCT00746668 study?
This clinical trial studies the following conditions: Retinal Degeneration, Age-related Maculopathy.
What interventions are being tested in trial NCT00746668?
The interventions under investigation include: Module 1: Visual Awareness and Eccentric Viewing (BEHAVIORAL), Module 2: Control of Reading Eye Movements (BEHAVIORAL), Module 3: Reading Practice with RSVP (BEHAVIORAL).
Who is sponsoring clinical trial NCT00746668?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00746668 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00746668's enrollment target sits among peer trials
36 11th of 17 higher than 7 of 17 other Retinal Degeneration trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinal Degeneration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Cell Collection to Study Eye Diseases
RECRUITING
-
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001
RECRUITING · Phase 1
-
Adaptive Optics Imaging of Outer Retinal Diseases
RECRUITING
-
Rod and Cone Mediated Function in Retinal Disease
RECRUITING
-
Oral Metformin for Treatment of ABCA4 Retinopathy
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia